Results

Total Results: 1,653 records

Showing results for "described".

  1. effectivehealthcare.ahrq.gov/sites/default/files/pdf/medication-adherence-interventions_research-protocol.pdf
    August 18, 2011 - Moreover, as described below in the section discussing health disparities, medication adherence is particularly … Burden, Scope, and Prevalence of the Problem As described in this section, poor adherence is very … The steps that we will take to accomplish the literature review are described below. … As described above, all results will be tracked in an EndNote database. … We will also abstract intervention characteristics as described in KQ 3.
  2. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cad-women-diagnosis_executive.pdf
    June 01, 2012 - From Stakeholders The Evidence-based Practice Center (EPC) followed AHRQ’s recommended methodology, described … We evaluated the quality of individual studies using the approach described in AHRQ’s Methods Guide … We used the Rutter and Gatsonis12 SROC curve as described by Arends et al.,13 and it is presented in … the Body of Evidence The strength of evidence for each Key Question was assessed using the approach described … Predictors of diagnostic accuracy in women Insufficient 11 studies (4 good quality, 5 fair, 2 poor) described
  3. effectivehealthcare.ahrq.gov/sites/default/files/related_files/infantile-hemangioma_disposition-comments.pdf
    January 15, 2016 - The studies are well described, with few exceptions described below. … Again, the latent model is described in paragraphs 3 and 4 of Appendix D. … Methods for dealing with these multiple scales are described in Appendix D. … , not supported by other literature) and another outlier described the 50% rate of sleep disturbance … We attempted to ascertain that the lesions described were true IH but acknowledge that that determination
  4. effectivehealthcare.ahrq.gov/sites/default/files/assessing-applicability.ppt
    January 01, 2009 - In the intervention column, the type of surgical procedure is described. … In the comparator column, the comparator is described, and then the extent of use of other medications … Important limitations of the applicability of the evidence should be described within each summary conclusion … Finally, we learned that important limitations of the applicability of the evidence should be described
  5. effectivehealthcare.ahrq.gov/sites/default/files/related_files/autism_disposition-comments.pdf
    November 01, 2010 - Treatments described in this category are focused on delivering an exogenous substance, typically a … Methods and findings from individual studies are described accurately. … friendship training post treatment and at follow up are described. … The use of the quality components is described in the Methods of the report. … Results The studies were described and arrayed well in tabular format.
  6. DRN: Report 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/distributed-network-safety_research.pdf
    July 01, 2009 - The Need for a Large, Distributed Research Network As described above, AHRQ and others (e.g., the IOM … Summary of Existing Networks Much can be learned from the activities of the networks described above … To help illustrate network capabilities, the steps described a range of activities from development … The specifications of the proof-of-principle are described below. 9.1. … The primary and secondary objectives of the proof-of-principle are described below.
  7. effectivehealthcare.ahrq.gov/sites/default/files/related_files/thromboembolism-update-disposition.pdf
    June 22, 2017 - The used defendable methods and described things pretty well so as to avoid ambiguity. … This is described in the Results. … TEP Reviewer #1 Methods The methods are clearly described and complete. … The search strategies were explicitly described, and were appropriate for the key questions. … Otherwise, characteristics of the studies is clearly described.
  8. effectivehealthcare.ahrq.gov/sites/default/files/related_files/autism-update_disposition-comments.pdf
    August 06, 2014 - Peer Reviewer #4 Discussion/ Conclusion Limitation were described adequately. … TEP Reviewer #2 Discussion/ Conclusion the implications are appropriately stated; limitations described … Peer reviewer #1 General The target population is well described. … The methods for arriving at our assessments are described in the methods section of the full report. … The inclusion and exclusion criteria are described fully in the methods section of the full report.
  9. effectivehealthcare.ahrq.gov/sites/default/files/related_files/scope-communicating-evolving-evidence-white-paper_0.pdf
    June 01, 2025 - A prior white paper described challenges and practical and methodological considerations encountered … A prior white paper2 drew on experience of the first year of the living review3 and described practical … Based on the considerations described above, we plan to prospectively expand the scope of the living … The quarterly surveillance reports in the interim were briefer (7 to 10 pages), and described the new … in the frequency of updates occur in the future, these will be documented as protocol changes, as described
  10. effectivehealthcare.ahrq.gov/sites/default/files/pdf/cerebral-palsy-feeding_research-protocol.pdf
    June 12, 2012 - Random sequence generation method should produce comparable groups Not described in sufficient … risk of bias Reviewer Assessment Performance bias Blinding (participants and personnel) Described … Not described in sufficient detail Judgment: Blinding (participants and personnel) □ High … □ Low □ Unclear Detection bias Blinding (outcome assessment) Described all measures used, … Not described in sufficient detail Judgment: Blinding (outcome assessment) □ High □ Low □
  11. effectivehealthcare.ahrq.gov/sites/default/files/related_files/weight-loss-surgery_disposition-comments.pdf
    June 05, 2013 - The matter of “…an aversion to high-carbohydrate foods…” could also be described as a learned behavior … This procedure is a modification of the BPD described below in the introduction. … Peer Reviewer 5 Methods I found the methods very confusing, as they were inadequately described We … The limitations of the included studies are well-described and defined. … Chiellini is now described in the results section on small cohort studies.
  12. effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypertension-pulmonary-arterial_executive.pdf
    April 01, 2013 - They described results for individual domains. … When a meta-analysis was not appropriate we described the reasons, presented data in tabular form, … studies. 9 Applicability We assessed applicability across our KQs using the PICOTS format as described … There was also concern that the population was not adequately described to assess applicability, included … There was also concern that the population was not always adequately described to assess applicability
  13. effectivehealthcare.ahrq.gov/sites/default/files/pdf/colorectal-cancer-liver-metastases-therapies_research-protocol.pdf
    September 27, 2012 - o Were inclusion/exclusion criteria clearly described? … o Were baseline prognostic characteristics clearly described and groups shown to be comparable? … characteristics proposed by Carey and Boden,30 as follows: o Clearly defined question o Well-described … study population o Well-described intervention o Use of validated outcome measures o Appropriate … statistical analyses o Well-described results o Discussion and conclusion supported by data o
  14. effectivehealthcare.ahrq.gov/sites/default/files/pdf/pelvic-pain_research-protocol.pdf
    February 16, 2011 - An outcome measure described as validated by an authoritative professional clinical organization (reference … An outcome measure described as validated by the authors of the index study, with a linked reference … An outcome measure described as validated by the authors of the index study, without a linked reference … An outcome measure that is not described as validated by the authors of the index study and is not a … Core Outcome Measure as described above in 1a For studies that meet the conditions of the second-round
  15. effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-introduction_methods.pdf
    July 01, 2012 - personal experience and judgment, and to maintain consistency as much as possible with the principles described … This value has been reiterated in other recommendations for reviewers.12–14 In 1991, Woolf described … a conceptual model that he termed the “Evidence Model,”15 and in 1994, he described this same model … with the current standard approach to classifying contexts, the PICOTS typology, which is further described
  16. effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-radiation_technical-brief.pdf
    November 01, 2009 - Most studies reported patient relevant-clinical outcomes: 151 studies (62 percent) described overall … The complete search strategy is described in Appendix B. … Mean or Median Ages Only 7 papers focused on pediatric or adolescent populations, and they described … Overall, 46 studies described more than 300 people. … Cancer specific outcomes were also described.
  17. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-202-thermoplasty-comments.pdf
    December 14, 2017 - We described the reduction in ED visits found in the AIR 2 trial, and judged the strength of evidence … Study characteristics are well described. Thank you. … The approach is described more fully in the EPC Methods Guidance, available on the AHRQ Effective … The 2 year follow-up data from 279 patients treated in PAS2 described earlier in these comments and … While bronchial artery embolization has been described as effective in a number of case series for
  18. effectivehealthcare.ahrq.gov/sites/default/files/selection-of-data-sources-chapter-8.pptx
    January 01, 2013 - The observational research designs that often require primary data collection are described below: Prospective … The observational research designs that require primary data collection are described here.
  19. effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-cholestorol-medications_disposition-comments.pdf
    March 10, 2010 - for confusion, we believe that it is critical that this limited focus be consistently and clearly described … We also think that the conclusions that are described in the report should be very carefully written … Methods from publication described below: “In this study, following a 6-week double-blind phase in which … Also add LDL-C results to the Table on page The trial population is better described under CPK results … (Ref 35) Davidson was penalized because "no intention-to-treat analysis was described".
  20. Untitled (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/aggression_research-protocol.pdf
    October 05, 2015 - The latter include, for example, the medication protocols described in the emergency department-focused … Other strategies targeted to decrease aggression for those who are actively aggressive, as describeddescribed!in!project!BETA! •! Any!intervention,!or!combination!of! interventions,!different!from! … described!above!for!KQs!1a!and!2a! All!KQs! •! A!study!with!no!comparison!group! •! For! … described!above!for!KQs! 1b/1c!and!2b/2c! •! Seclusion!or!restraint!(for!1b!and!2b!only):! !

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: